Janus Henderson Group PLC Mirum Pharmaceuticals, Inc. Call Options Transaction History
Janus Henderson Group PLC
- $188 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$335 Million16.29% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$165 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$142 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$133 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$124 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.87B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...